1. Home
  2. LABT vs CHOW Comparison

LABT vs CHOW Comparison

Compare LABT & CHOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$0.20

Market Cap

670.6K

Sector

Health Care

ML Signal

N/A

Logo ChowChow Cloud International Holdings Limited Ordinary Shares

CHOW

ChowChow Cloud International Holdings Limited Ordinary Shares

N/A

Current Price

$4.36

Market Cap

732.2K

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
LABT
CHOW
Founded
2006
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
670.6K
732.2K
IPO Year
2026
2024

Fundamental Metrics

Financial Performance
Metric
LABT
CHOW
Price
$0.20
$4.36
Analyst Decision
Analyst Count
0
0
Target Price
★ $7.50
N/A
AVG Volume (30 Days)
607.7K
★ 7.6M
Earning Date
11-18-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.80
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.20
52 Week High
$6.85
$12.05

Technical Indicators

Market Signals
Indicator
LABT
CHOW
Relative Strength Index (RSI) 16.87 89.54
Support Level N/A $0.35
Resistance Level $2.13 N/A
Average True Range (ATR) 0.06 0.61
MACD 0.01 0.35
Stochastic Oscillator 1.52 59.36

Price Performance

Historical Comparison
LABT
CHOW

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About CHOW ChowChow Cloud International Holdings Limited Ordinary Shares

ChowChow Cloud International Holdings Ltd provides one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey, from consulting, deployment, and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment, (ii) professional IT services comprising capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations, including infrastructure applications.

Share on Social Networks: